Table S1.
Parameters of kidney damage|| | Groups | OR (95% CI) | |||
---|---|---|---|---|---|
Model 1* | Model 2† | Model 3‡ | Model 4§ | ||
eGFR <60 ml·min−1·1.73 m−2 | Low-stable group | 1 | 1 | 1 | 1 |
Moderate-stable group | 1.96 (1.24–3.07) | 1.58 (1.01–2.50) | 1.59 (0.98–2.60) | 1.45 (0.86–2.46) | |
Moderate increasing group | 2.46 (1.46–4.12) | 1.63 (0.96–2.77) | 1.65 (0.90–3.03) | 1.37 (0.84–2.78) | |
Elevated decreasing group | 3.20 (1.96–5.22) | 2.22 (1.34–3.65) | 2.15 (1.22–3.80) | 1.74 (0.86–3.50) | |
Elevated stable group | 4.57 (2.76–7.56) | 2.81 (1.68–4.72) | 2.70 (1.51–4.83) | 2.01 (0.90–4.50) | |
P-trend | <0.001 | 0.001 | 0.009 | 0.446 | |
Slope of SBP | 0.92 (0.79–1.06) | 0.96 (0.81–1.15) | |||
SBP_06 | 1.00 (0.99–1.01) | ||||
Positive urinary protein | Low-stable group | 1 | 1 | 1 | 1 |
Moderate-stable group | 1.57 (1.10–2.24) | 1.50 (1.04–2.15) | 1.46 (1.00–2.13) | 1.34 (0.89–2.03) | |
Moderate increasing group | 3.21 (2.17–4.73) | 2.97 (2.00–4.43) | 1.99 (1.26–3.14) | 1.68 (0.98–2.89) | |
Elevated decreasing group | 2.87 (1.95–4.23) | 2.67 (1.80–3.97) | 3.20 (2.02–5.06) | 2.63 (1.49–4.64) | |
Elevated stable group | 4.17 (2.79–6.42) | 3.82 (2.52–5.79) | 3.17 (1.99–5.05) | 2.39 (1.25–4.56) | |
P-trend | <0.001 | <0.001 | <0.001 | 0.007 | |
Slope of SBP | 1.22 (1.08–1.37) | 1.29 (1.12–1.50) | |||
SBP_06 | 1.00 (0.99–1.01) | ||||
eGFR <60 ml·min−1· 1.73 m−2 and/or positive urinary protein | Low-stable group | 1 | 1 | 1 | 1 |
Moderate-stable group | 1.65 (1.24–2.21) | 1.47 (1.10–1.97) | 1.40 (1.02–1.90) | 1.25 (0.89–1.75) | |
Moderate increasing group | 2.84 (2.05–3.94) | 2.27 (1.62–3.17) | 1.64 (1.12–2.41) | 1.31 (0.83–2.07) | |
Elevated decreasing group | 2.93 (2.13–4.03) | 2.40 (1.74–3.33) | 2.59 (1.78–3.77) | 1.98 (1.24–3.17) | |
Elevated stable group | 4.16 (2.97–5.83) | 3.18 (2.25–4.50) | 2.63 (1.78–3.87) | 1.86 (1.08–3.19) | |
P-trend | <0.001 | <0.001 | <0.001 | 0.034 | |
Slope of SBP | 1.11 (1.01–1.23) | 1.19 (1.06–1.35) | |||
SBP_06 | 1.01 (1.00–1.01) | ||||
eGFR reduced ≥30% | Low-stable group | 1 | 1 | 1 | 1 |
Moderate-stable group | 1.12 (0.80–1.57) | 1.06 (0.75–1.48) | 1.09 (0.74–1.62) | 1.13 (0.73–1.75) | |
Moderate increasing group | 1.21 (0.79–1.84) | 1.07 (0.69–1.65) | 1.36 (0.79–2.35) | 1.40 (0.73–2.69) | |
Elevated decreasing group | 1.86 (1.28–2.70) | 1.67 (1.14–2.46) | 1.77 (1.09–2.88) | 1.92 (1.01–3.64) | |
Elevated stable group | 1.89 (1.24–2.87) | 1.64 (1.06–2.53) | 2.10 (1.23–3.58) | 2.20 (1.03–4.71) | |
P-trend | 0.001 | 0.006 | 0.011 | 0.119 | |
Slope of SBP | 0.87 (0.76–1.01) | 0.86 (0.73–1.02) | |||
SBP_06 | 0.99 (0.98–1.01) |
*Model 1: With different parameters as the dependent variable, different BP trajectory group as independent variable, low-stable group as the control group; †Model 2: Adjusting for age, gender on the basis of Model 1; ‡Model 3: Adjusting for FBG, BMI, eGFR, high cholesterol, smoking, alcohol consumption, physical activity, taking antihypertensive medications, slope of SBP on the basis of Model 2; §Model 4: Adjusting for SBP in 2006 on the basis of Model 3; ||Parameters of kidney damage: “eGFR ≥60 ml·min−1·1.73 m−2” = 0, “eGFR <60 ml·min−1 ·1.73 m−2” = 1; “negative urine protein” = 0, “positive urinary protein” = 1; “eGFR ≥60 ml·min−1 ·1.73 m−2 and negative urine protein” = 0, “eGFR <60 ml·min−1 ·1.73 m−2 or urine protein positive” = 1; “eGFR decline <30%” = 0, “eGFR decline ≥30%” = 1; gender: “female” = 0, “male” = 1; high cholesterol, smoking, alcohol consumption, exercise, taking antihypertensive medications: “No” = 0,”Yes” = 1. SBP: Systolic blood pressure; BMI: Body mass index; FBG: Fasting blood glucose; eGFR: Estimated glomerular filtration rate; BP: Blood pressure; OR: Odds ratio; CI: Confidence interval.